AI assistant
Sending…
RESMED INC — Director's Dealing 2010
May 12, 2010
30071_dirs_2010-05-12_2f4851a7-3560-420d-ac85-8ccde34610ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-05-10
Reporting Person: PENDARVIS DAVID (Sr. VP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-05-10 | ResMed Common Stock | M | 17500 | $31.04 | Acquired | 21297.05 | Direct |
| 2010-05-10 | ResMed Common Stock | S | 17500 | $65.60 | Disposed | 3797.05 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-10 | ResMed Common Stock Options | $31.04 | M | 17500 | Disposed | 2015-11-20 | ResMed Common Stock (17500) | Direct |
Footnotes
F1: Represents first date options became exercisable.
F2: Includes 256.318 shares purchased on April 30, 2010, pursuant to ResMed's Employee Stock Purchase Plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29